Arruda-Olson Adelaide M, Reeder Guy S, Bell Malcolm R, Weston Susan A, Roger Véronique L
Division of Cardiovascular Diseases and Internal Medicine and the Department of Health Sciences Research, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Circ Cardiovasc Qual Outcomes. 2009 Nov;2(6):656-62. doi: 10.1161/CIRCOUTCOMES.108.831024. Epub 2009 Sep 1.
The relationship between neutrophils and outcomes post-myocardial infarction (MI) is not completely characterized. We examined the associations of neutrophil count with mortality and post-MI heart failure (HF) and their incremental value for risk discrimination in the community.
MI was diagnosed with cardiac pain, biomarkers, and Minnesota coding of the ECG. Neutrophil count at presentation, reported as counts x10(9)/L, was categorized by tertiles (lower tertile, <5.7; middle tertile, 5.7 to 8.5; upper tertile, >8.5). From 1979 to 2002, 2047 incident MIs occurred in Olmsted County, Minn (mean age, 68+/-14 years; 44% women). Median (25th to 75th percentile) neutrophil count was 7.0 (5.1 to 9.5). Within 3 years post-MI, 577 patients died, and 770 developed HF. Overall survival and survival free of HF decreased with increased neutrophil tertile (P<0.001). Compared with the lower tertile, the age and sex adjusted hazard ratio for death was 1.44 (95% CI, 1.14 to 1.81) for the middle tertile and 2.60 (95% CI, 2.10 to 3.22) for the upper tertile (P<0.001). Similarly, for HF, the hazard ratio was 1.32 (95% CI, 1.09 to 1.59) for the middle and 2.12 (95% CI, 1.77 to 2.53) for the upper tertile (P<0.001). These associations persisted after adjustment for risk factors, comorbidities, Killip class, revascularization, and ejection fraction. Neutrophil count improved risk discrimination as indicated by increases in the area under the receiver operating characteristic curves (all P<0.05) and by the integrated discrimination improvement analysis (all P<0.001).
In the community, the neutrophil count was strongly and independently associated with death and HF post-MI and improved risk discrimination over traditional predictors.
中性粒细胞与心肌梗死(MI)后预后之间的关系尚未完全明确。我们研究了中性粒细胞计数与死亡率、MI后心力衰竭(HF)的关联及其在社区中对风险分层的增量价值。
通过胸痛、生物标志物及心电图的明尼苏达编码诊断MI。就诊时的中性粒细胞计数(报告为计数×10⁹/L)按三分位数分类(低三分位数,<5.7;中三分位数,5.7至8.5;高三分位数,>8.5)。1979年至2002年,明尼苏达州奥尔姆斯特德县发生了2047例新发MI(平均年龄68±14岁;44%为女性)。中性粒细胞计数的中位数(第25至75百分位数)为7.0(5.1至9.5)。MI后3年内,577例患者死亡,770例发生HF。随着中性粒细胞三分位数的增加,总体生存率和无HF生存率下降(P<0.001)。与低三分位数相比,中三分位数的年龄和性别调整后死亡风险比为1.44(95%CI,1.14至1.81),高三分位数为2.60(P<0.001)。同样,对于HF,中三分位数的风险比为1.32(95%CI,1.09至1.59),高三分位数为2.12(P<0.001)。在调整了危险因素、合并症、Killip分级、血运重建和射血分数后,这些关联仍然存在。中性粒细胞计数改善了风险分层,表现为受试者工作特征曲线下面积增加(所有P<0.05)和综合判别改善分析(所有P<0.001)。
在社区中,中性粒细胞计数与MI后死亡和HF密切相关且独立相关,并优于传统预测指标改善了风险分层。